GW PHARMACEUTICALS PLC Earnings Per Share (Diluted)
GW PHARMACEUTICALS PLC reported Earnings Per Share (Diluted) of -$0.05 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2021-05-03
- GW PHARMACEUTICALS PLC earnings per share, diluted for the quarter ending 2021-03-31 was -$0.05.
- GW PHARMACEUTICALS PLC earnings per share, diluted for the quarter ending 2020-12-31 was -$77.38.
- GW PHARMACEUTICALS PLC earnings per share, diluted for the quarter ending 2020-09-30 was -$0.03.
- GW PHARMACEUTICALS PLC earnings per share, diluted for the quarter ending 2020-06-30 was -$0.02, a 109.52% decline year-over-year.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.05 10-Q · filed 2021-05-03 | -$0.26 derived: net income ÷ weighted average shares · filed 2021-05-03 | -$0.48 derived: net income ÷ weighted average shares · filed 2021-05-03 | -$0.74 derived: net income ÷ weighted average shares · filed 2021-05-03 |
| 2020-12-31 | -$77.38 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$109.79 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$133.35 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.62 derived: net income ÷ weighted average shares · filed 2021-05-03 |
| 2020-09-30 | -$0.03 10-Q · filed 2020-11-05 | -$55.91 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.08 10-Q · filed 2020-11-05 | -$0.58 derived: net income ÷ weighted average shares · filed 2021-05-03 |
| 2020-06-30 | -$0.02 10-Q · filed 2020-08-07 | -$0.04 10-Q · filed 2020-08-07 | -$0.33 derived: net income ÷ weighted average shares · filed 2021-05-03 | -$0.59 derived: net income ÷ weighted average shares · filed 2021-05-03 |
| 2020-03-31 | -$0.02 10-Q · filed 2021-05-03 | -$0.18 derived: net income ÷ weighted average shares · filed 2021-05-03 | -$0.37 derived: net income ÷ weighted average shares · filed 2021-05-03 | $0.35 derived: net income ÷ weighted average shares · filed 2021-05-03 |
| 2019-12-31 | -$0.07 10-K · filed 2021-02-26 | -$103.94 derived: net income ÷ weighted average shares · filed 2021-02-26 | $109.73 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$24.18 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2019-09-30 | -$0.04 10-K · filed 2021-02-26 | $176.05 derived: net income ÷ weighted average shares · filed 2021-02-26 | $0.04 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.21 10-K · filed 2021-02-26 | $0.08 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | -$0.14 10-K · filed 2021-02-26 | |||
| 2018-09-30 | -$0.23 10-Q · filed 2019-11-06 | -$0.48 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.68 10-Q · filed 2019-11-06 | |
| 2018-06-30 | -$0.25 10-Q · filed 2019-08-07 | -$0.45 10-Q · filed 2019-08-07 |